Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 312 Issue 5991, 15 November 1984

Opinion

  • The near-collapse of the British research enterprise has become a public issue. The extra funds announced this week may be a palliative, but cannot be a cure. The House of Lords has the luck to look closer.

    Opinion

    Advertisement

  • New categories of drugs for which British patients must pay set dangerous precedents.

    Opinion
Top of page ⤴

News

Top of page ⤴

Correspondence

Top of page ⤴

News & Views

Top of page ⤴

Autumn Books

Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Matters Arising

Top of page ⤴
Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Quick links